Lung perfusion in pulmonary hypertension – results from the RESPIRE study

P. Hughes (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), F. Wilson (Stevenage, United Kingdom), M. Cogliano (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), A. Cahn (Stevenage, United Kingdom), L. Kendall (Stevenage, United Kingdom), D. Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom)

Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session: Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session type: E-poster session
Number: 1519
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Hughes (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), F. Wilson (Stevenage, United Kingdom), M. Cogliano (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), A. Cahn (Stevenage, United Kingdom), L. Kendall (Stevenage, United Kingdom), D. Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). Lung perfusion in pulmonary hypertension – results from the RESPIRE study. 1519

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: